BHC Q1 Earnings Miss Estimates, Sales Grow on Salix & Solta StrengthZacks Investment Research • 04/30/26
Compared to Estimates, Bausch (BHC) Q1 Earnings: A Look at Key MetricsZacks Investment Research • 04/30/26
Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular DegenerationBusiness Wire • 04/23/26
Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online OrderingPRNewsWire • 04/14/26
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced UpdateBusiness Wire • 04/08/26
Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in EuropeBusiness Wire • 04/07/26
Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship ProgramPRNewsWire • 03/26/26
Bausch (BHC) Down 15.2% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/20/26
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in CanadaPRNewsWire • 02/23/26
Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now?Zacks Investment Research • 02/20/26
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) MicrospheresPRNewsWire • 02/19/26
Curious about Bausch (BHC) Q4 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 02/17/26